PATENT CLAIM ANALYSIS

Application Number: 15902316
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "363000"]

Abstract:
Provided herein are methods for repairing central nervous system, particularly brain, lesions in a subject comprising orally administering a carbonic anhydrase inhibitor.

Claim (Index 3):
The method of  claim 1 , wherein the carbonic anhydrase inhibitor is acetazolamide (ACZ), dichlorphenamide, methazolamide, dorzolamide, or brinzolamide.

Metadata:
- Claim Count in Document: 52.0
- Percentile: 88.0
- Lexical Diversity: 1.08696
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15541944', '12456883', '15201300', '13848811', '15597021']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.636829705840221
- 35 USC 102 Novelty (BERT): 0.5145837888513309
- Combined Prediction Score: 0.624605114141332
- Mean Citation Score: 180.300646
- Max Citation Score: 197.02379
- Similarity Product: 115.28465474669754

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test